1. Anticancer effects of some novel dichloroacetophenones through the inhibition of pyruvate dehydrogenase kinase 1
    Shao-Lin Zhang et al, 2018, European Journal of Pharmaceutical Sciences CrossRef
  2. Microenvironmental control of glucose metabolism in tumors by regulation of pyruvate dehydrogenase
    Tereza Golias et al, 2019, International Journal of Cancer CrossRef
  3. Glycolysis-induced drug resistance in tumors—A response to danger signals?
    Fabrizio Marcucci et al, 2021, Neoplasia CrossRef
  4. Phenylbutyrate and Dichloroacetate Enhance the Liquid-Stored Boar Sperm Quality via PDK1 and PDK3
    Zhihua Guo et al, 2023, International Journal of Molecular Sciences CrossRef
  5. Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: A role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation
    Ajay Kumar et al, 2013, Toxicology and Applied Pharmacology CrossRef
  6. Glucose metabolism in gastric cancer: The cutting-edge
    Lian-Wen Yuan, 2016, World Journal of Gastroenterology CrossRef
  7. Deregulation of glycolysis in cancer: glyceraldehyde-3-phosphate dehydrogenase as a therapeutic target
    George S Krasnov et al, 2013, Expert Opinion on Therapeutic Targets CrossRef
  8. Design and characterization of α -lipoic acyl shikonin ester twin drugs as tubulin and PDK1 dual inhibitors
    Hong-Yan Lin et al, 2018, European Journal of Medicinal Chemistry CrossRef
  9. Identification of Novel Pyruvate Dehydrogenase Kinase 1 (PDK1) Inhibitors by Kinase Activity-Based High-Throughput Screening for Anticancer Therapeutics
    Wen Zhang et al, 2018, ACS Combinatorial Science CrossRef
  10. New insights into the core Hippo signaling and biological macromolecules interactions in the biology of solid tumors
    Solmaz Mohammadi et al, 2020, BioFactors CrossRef
  11. Improving Patient Selection for 18F-FDG PET Scanning in the Staging of Gastric Cancer
    Yui Kaneko et al, 2015, Journal of Nuclear Medicine CrossRef
  12. Moonlighting Metabolic Enzymes in Cancer: New Perspectives on the Redox Code
    Jingwen Jiang et al, 2021, Antioxidants & Redox Signaling CrossRef
  13. Novel shikonin derivatives suppress cell proliferation, migration and induce apoptosis in human triple-negative breast cancer cells via regulating PDK1/PDHC axis
    Qingqing Chen et al, 2022, Life Sciences CrossRef
  14. Frequent overexpression of PDK1 in primary nasopharyngeal carcinoma is associated with poor prognosis
    Guangzao Xiang et al, 2016, Pathology - Research and Practice CrossRef
  15. Emerging Anti-cancer Targets in Mitochondria
    Petr Ježek et al, 2014, Mitochondria: The Anti- cancer Target for the Third Millennium CrossRef
  16. Targeting cancer stem cell pathways for cancer therapy
    Liqun Yang et al, 2020, Signal Transduction and Targeted Therapy CrossRef
  17. Pyruvate dehydrogenase kinase expression and metabolic changes following dichloroacetate exposure in anoxic human colorectal cancer cells
    Nelson Ho et al, 2015, Experimental Cell Research CrossRef
  18. Rev-erbα inhibits proliferation by reducing glycolytic flux and pentose phosphate pathway in human gastric cancer cells
    Linlin Tao et al, 2019, Oncogenesis CrossRef
  19. Elucidation of the Interaction Loci of the Human Pyruvate Dehydrogenase Complex E2·E3BP Core with Pyruvate Dehydrogenase Kinase 1 and Kinase 2 by H/D Exchange Mass Spectrometry and Nuclear Magnetic Resonance
    Junjie Wang et al, 2015, Biochemistry CrossRef
  20. Tumorigenesis and Metabolism Disorder
    Fan Yang et al, 2019, Virus Infection and Tumorigenesis CrossRef
  21. Overcoming 5-Fu resistance in human non-small cell lung cancer cells by the combination of 5-Fu and cisplatin through the inhibition of glucose metabolism
    Jun-gang Zhao et al, 2014, Tumor Biology CrossRef
  22. Glucose transporter 1 and prognosis in cancer
    Hiroshi Sawayama et al, 2019, Molecular Nutrition: Carbohydrates CrossRef
  23. Stimuli-Responsive Adaptive Nanotoxin to Directly Penetrate the Cellular Membrane by Molecular Folding and Unfolding
    Youngdo Jeong et al, 2022, Journal of the American Chemical Society CrossRef
  24. Dichloroacetate and cancer: New home for an orphan drug?
    Shyam Kankotia et al, 2014, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  25. Hypoxia-driven metabolic heterogeneity and immune evasive behaviour of gastrointestinal cancers: Elements of a recipe for disaster
    Ashish Kumar Mishra et al, 2022, Cytokine CrossRef
  26. Molecular hybrids: A five-year survey on structures of multiple targeted hybrids of protein kinase inhibitors for cancer therapy
    Osama M. Soltan et al, 2021, European Journal of Medicinal Chemistry CrossRef
  27. Common Core Genes Play Vital Roles in Gastric Cancer With Different Stages
    Zhiyuan Yu et al, 2022, Frontiers in Genetics CrossRef
  28. Cancer Stem Cells in Tumor Microenvironment of Adenocarcinoma of the Stomach, Colon, and Rectum
    Jose Francisco Islas et al, 2022, Cancers CrossRef
  29. Dichloroacetate affects proliferation but not survival of human colorectal cancer cells
    L. M. Delaney et al, 2015, Apoptosis CrossRef
  30. Discovery of novel pyruvate dehydrogenase kinases inhibitors by screening of an in-house small molecule library for anti-lung cancer therapeutics
    Fuyun Guo et al, 2019, Bioorganic & Medicinal Chemistry Letters CrossRef
  31. Development of dual inhibitors targeting pyruvate dehydrogenase kinases and human lactate dehydrogenase A: High-throughput virtual screening, synthesis and biological validation
    Sichuan Xiang et al, 2020, European Journal of Medicinal Chemistry CrossRef
  32. Dichloroacetate Radiosensitizes Hypoxic Breast Cancer Cells
    Sven de Mey et al, 2020, International Journal of Molecular Sciences CrossRef
  33. Overcoming 5-Fu Resistance of Colon Cells through Inhibition of Glut1 by the Specific Inhibitor WZB117
    Wei Liu et al, 2014, Asian Pacific Journal of Cancer Prevention CrossRef
  34. Phenyl butyrate inhibits pyruvate dehydrogenase kinase 1 and contributes to its anti-cancer effect
    Wen Zhang et al, 2017, European Journal of Pharmaceutical Sciences CrossRef
  35. Synthesis and biological evaluation of (R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionamides as pyruvate dehydrogenase kinase 1 (PDK1) inhibitors to reduce the growth of cancer cells
    Shao-Lin Zhang et al, 2017, European Journal of Pharmaceutical Sciences CrossRef
  36. Isoform Switch of Pyruvate Kinase M1 Indeed Occurs but Not to Pyruvate Kinase M2 in Human Tumorigenesis
    Cheng Zhan et al, 2015, PLOS ONE CrossRef
  37. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis
    Yulin Liu et al, 2016, PLOS ONE CrossRef
  38. Metabolic Response of Pancreatic Carcinoma Cells under Treatment with Dichloroacetate
    Benedikt Feuerecker et al, 2021, Metabolites CrossRef
  39. Metabolic interplay between glycolysis and mitochondrial oxidation: The reverse Warburg effect and its therapeutic implication
    Minjong Lee, 2015, World Journal of Biological Chemistry CrossRef
  40. Mitochondria in Cancer Energy Metabolism: Culprits or Bystanders?
    Aekyong Kim, 2015, Toxicological Research CrossRef
  41. Liquid Chromatography–Tandem Mass Spectrometry Method Revealed that Lung Cancer Cells Exhibited Distinct Metabolite Profiles upon the Treatment with Different Pyruvate Dehydrogenase Kinase Inhibitors
    Wen Zhang et al, 2018, Journal of Proteome Research CrossRef
  42. Allele-Specific MicroRNA-Mediated Regulation of a Glycolysis Gatekeeper PDK1 in Cancer Metabolism
    Sugarniya Subramaniam et al, 2021, Cancers CrossRef
  43. Hemistepsin A suppresses colorectal cancer growth through inhibiting pyruvate dehydrogenase kinase activity
    Ling Jin et al, 2020, Scientific Reports CrossRef
  44. Identification of Novel Resorcinol Amide Derivatives as Potent and Specific Pyruvate Dehydrogenase Kinase (PDHK) Inhibitors
    Hanna Cho et al, 2019, Journal of Medicinal Chemistry CrossRef
  45. Targeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy
    Saleha Anwar et al, 2021, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  46. PDK1 promotes ovarian cancer metastasis by modulating tumor-mesothelial adhesion, invasion, and angiogenesis via α5β1 integrin and JNK/IL-8 signaling
    Michelle K. Y. Siu et al, 2020, Oncogenesis CrossRef
  47. Editor’s Pick: Pyruvate Kinase and Gastric Cancer: A Potential Marker
    Filipa Macedo et al, 2018, European Medical Journal CrossRef
  48. Increased Pyruvate Dehydrogenase Kinase 4 Expression in Lung Pericytes Is Associated with Reduced Endothelial-Pericyte Interactions and Small Vessel Loss in Pulmonary Arterial Hypertension
    Ke Yuan et al, 2016, The American Journal of Pathology CrossRef
  49. Enzymes involved in l-lactate metabolism in humans
    M. Adeva et al, 2013, Mitochondrion CrossRef
  50. High-throughput screening of novel pyruvate dehydrogenase kinases inhibitors and biological evaluation of their in vitro and in vivo antiproliferative activity
    Dong-Mei Wu et al, 2019, European Journal of Medicinal Chemistry CrossRef
  51. Lactate: a rising star in tumors and inflammation
    Hui Liu et al, 2024, Frontiers in Immunology CrossRef
  52. Energy metabolism: a new target for gastric cancer treatment
    Jiangrong Liu et al, 2023, Clinical and Translational Oncology CrossRef
  53. Combined Targeting of PDK1 and EGFR Triggers Regression of Glioblastoma by Reversing the Warburg Effect
    Kiran Kumar Velpula et al, 2013, Cancer Research CrossRef
  54. PDK-1 mediated Hippo–YAP–IRS2 signaling pathway and involved in the apoptosis of non-small cell lung cancer cells
    Guofang Wang et al, 2019, Bioscience Reports CrossRef
  55. Hypoxic repression of pyruvate dehydrogenase activity is necessary for metabolic reprogramming and growth of model tumours
    Tereza Golias et al, 2016, Scientific Reports CrossRef
  56. Metabolic codependencies in the tumor microenvironment and gastric cancer: Difficulties and opportunities
    Xihe Zhao et al, 2023, Biomedicine & Pharmacotherapy CrossRef
  57. Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma
    Surangkana Sanmai et al, 2019, Oncology Letters CrossRef
  58. Glycine metabolomic changes induced by anticancer agents in A549 cells
    Kaiqiang Guo et al, 2020, Amino Acids CrossRef
  59. Immunohistochemical analysis of PDK1, PHD3 and HIF-1α expression defines the hypoxic status of neuroblastoma tumors
    Marzia Ognibene et al, 2017, PLOS ONE CrossRef
  60. Clinical impact of the Warburg effect in gastrointestinal cancer (Review)
    HIROSHI SAWAYAMA et al, 2014, International Journal of Oncology CrossRef
  61. Linking vitamin B1 with cancer cell metabolism
    Jason A Zastre et al, 2013, Cancer & Metabolism CrossRef
  62. Novel Therapeutic Targets of Tumor Metabolism
    Rigel J. Kishton et al, 2015, The Cancer Journal CrossRef
  63. Re-sensitization of 5-FU resistance by SPARC through negative regulation of glucose metabolism in hepatocellular carcinoma
    Hong-Wei Hua et al, 2015, Tumor Biology CrossRef
  64. Rational design of mitochondria-targeted pyruvate dehydrogenase kinase 1 inhibitors with improved selectivity and antiproliferative activity
    Biao Xu et al, 2018, European Journal of Medicinal Chemistry CrossRef
  65. PDK1: A New Therapeutic Target for Glioblastoma?
    Kiran Kumar Velpula et al, 2014, CNS Oncology CrossRef
  66. Targeting tumor-intrinsic SLC16A3 to enhance anti-PD-1 efficacy via tumor immune microenvironment reprogramming
    Ting Yu et al, 2024, Cancer Letters CrossRef
  67. Cancer metabolism regulation by phytonutrients
    Ammara Riaz et al, 2022, The Role of Phytonutrients in Metabolic Disorders CrossRef
  68. Cell competition with normal epithelial cells promotes apical extrusion of transformed cells through metabolic changes
    Shunsuke Kon et al, 2017, Nature Cell Biology CrossRef
  69. 1,2,4-Amino-triazine derivatives as pyruvate dehydrogenase kinase inhibitors: Synthesis and pharmacological evaluation
    Camilla Pecoraro et al, 2023, European Journal of Medicinal Chemistry CrossRef
  70. Fundamentals of the Warburg Effect in Cancer
    Pi Xian Zhang et al, 2019, Journal of Nutritional Oncology CrossRef
  71. Clinical Implication of Serine Metabolism-Associated Enzymes in Colon Cancer
    Shinkyo Yoon et al, 2015, Oncology CrossRef
  72. Pyruvate dehydrogenase kinase 1 contributes to cisplatin resistance of ovarian cancer through EGFR activation
    Meng Zhang et al, 2019, Journal of Cellular Physiology CrossRef
  73. Andrographolide suppresses aerobic glycolysis and induces apoptotic cell death by inhibiting pyruvate dehydrogenase kinase 1 expression
    Eun-Sun Yang et al, 2023, Oncology Reports CrossRef
  74. Bioenergetic alteration in gastrointestinal cancers: The good, the bad and the ugly
    Yu-De Chu et al, 2023, World Journal of Gastroenterology CrossRef
  75. Glioblastoma: Current Status, Emerging Targets, and Recent Advances
    Amandeep Thakur et al, 2022, Journal of Medicinal Chemistry CrossRef
  76. A Deregulated PI3K-AKT Signaling Pathway in Patients with Colorectal Cancer
    Tao Zhang et al, 2019, Journal of Gastrointestinal Cancer CrossRef
  77. Down-regulation of succinate dehydrogenase subunit B and up-regulation of pyruvate dehydrogenase kinase 1 predicts poor prognosis in recurrent nasopharyngeal carcinoma
    ZhiJian Dai et al, 2016, Tumor Biology CrossRef
  78. Identification of pyruvate dehydrogenase kinase 1 inhibitors with anti-osteosarcoma activity
    Aiping Fang et al, 2017, Bioorganic & Medicinal Chemistry Letters CrossRef
  79. Lactate in the Tumor Microenvironment: An Essential Molecule in Cancer Progression and Treatment
    Ricardo Pérez-Tomás et al, 2020, Cancers CrossRef
  80. Expression of Hexokinase-2 (HK2), Glutaminase-1 (GLS1) Y Fatty Acid Synthase (FASN) in Gastric Cancer and Their Prognostic Significance
    Elisa García-Martínez et al, SSRN Electronic Journal CrossRef
  81. β‐Asarone Increases Chemosensitivity by Inhibiting Tumor Glycolysis in Gastric Cancer
    Heyun Tao et al, 2020, Evidence-Based Complementary and Alternative Medicine CrossRef
  82. The Potential Role of Changes in the Glucose and Lipid Metabolic Pathways in Gastrointestinal Cancer Progression: Strategy in Cancer Therapy
    Gordon A. Ferns et al, 2021, Gastrointestinal Tumors CrossRef
  83. Reprogramming of glucose metabolism of cumulus cells and oocytes and its therapeutic significance
    Shogo Imanaka et al, 2022, Reproductive Sciences CrossRef
  84. Targeting PDK1 with dichloroacetophenone to inhibit acute myeloid leukemia (AML) cell growth
    Lijun Qin et al, 2016, Oncotarget CrossRef
  85. Poor prognosis of hexokinase 2 overexpression in solid tumors of digestive system: a meta-analysis
    Jiayuan Wu et al, 2017, Oncotarget CrossRef
  86. Glucose transporters 1, 3, 6, and 10 are expressed in gastric cancer and glucose transporter 3 is associated with UICC stage and survival
    Hans Anton Schlößer et al, 2017, Gastric Cancer CrossRef
  87. Dichloroacetyl Amides of 3,5-Bis(benzylidene)-4-piperidones Displaying Greater Toxicity to Neoplasms than to Non-Malignant Cells
    Mohammad Hossain et al, 2022, Medicines CrossRef
  88. Overexpression of pyruvate dehydrogenase kinase supports dichloroacetate as a candidate for cutaneous melanoma therapy
    Helena Pópulo et al, 2015, Expert Opinion on Therapeutic Targets CrossRef
  89. The Implications of PDK1–4 on Tumor Energy Metabolism, Aggressiveness and Therapy Resistance
    Emine Atas et al, 2020, Frontiers in Oncology CrossRef
  90. Bioenergetic modulation with dichloroacetate reduces the growth of melanoma cells and potentiates their response to BRAFV600E inhibition
    Cecilie Abildgaard et al, 2014, Journal of Translational Medicine CrossRef
  91. Unexpected Discovery of Dichloroacetate Derived Adenosine Triphosphate Competitors Targeting Pyruvate Dehydrogenase Kinase To Inhibit Cancer Proliferation
    Shao-Lin Zhang et al, 2016, Journal of Medicinal Chemistry CrossRef
  92. Chromatin as a sensor of metabolic changes during early development
    David Pladevall-Morera et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
  93. Global view of cognate kinase activation by the human pyruvate dehydrogenase complex
    Elena L. Guevara et al, 2017, Scientific Reports CrossRef
  94. Discovery of potent pyruvate dehydrogenase kinase inhibitors and evaluation of their anti-lung cancer activity under hypoxia
    Ronghua Yang et al, 2018, MedChemComm CrossRef
  95. Synthesis, biological evaluation and structure-activity relationship of novel dichloroacetophenones targeting pyruvate dehydrogenase kinases with potent anticancer activity
    Biao Xu et al, 2021, European Journal of Medicinal Chemistry CrossRef
  96. Development of dichloroacetamide pyrimidines as pyruvate dehydrogenase kinase inhibitors to reduce cancer cell growth: synthesis and biological evaluation
    Shao-Lin Zhang et al, 2016, RSC Advances CrossRef
  97. PDK1 promotes tumor cell proliferation and migration by enhancing the Warburg effect in non-small cell lung cancer
    Tao Liu et al, 2017, Oncology Reports CrossRef
  98. Dichloroacetate is an antimetabolite that antagonizes acetate and deprives cancer cells from its benefits: A novel evidence-based medical hypothesis
    Salah Mohamed El Sayed et al, 2019, Medical Hypotheses CrossRef
  99. Dichloroacetate attenuates hypoxia-induced resistance to 5-fluorouracil in gastric cancer through the regulation of glucose metabolism
    Yi Xuan et al, 2014, Experimental Cell Research CrossRef
  100. A dose- and time-dependent effect of oxythiamine on cell growth inhibition in non-small cell lung cancer
    Lin Bai et al, 2022, Cognitive Neurodynamics CrossRef
  101. Dichloroacetophenone biphenylsulfone ethers as anticancer pyruvate dehydrogenase kinase inhibitors in non-small cell lung cancer models
    Yizhen Guo et al, 2023, Chemico-Biological Interactions CrossRef
  102. Mitochondria and cancer chemoresistance
    Flora Guerra et al, 2017, Biochimica et Biophysica Acta (BBA) - Bioenergetics CrossRef
  103. Is an Entropy-Based Approach Suitable for an Understanding of the Metabolic Pathways of Fermentation and Respiration?
    Roberto Zivieri et al, 2017, Entropy CrossRef
  104. Gastric Cancer Stem Cells: A Glimpse on Metabolic Reprogramming
    Martina Addeo et al, 2021, Frontiers in Oncology CrossRef